Last €23.11 EUR
Change Today -0.56 / -2.37%
Volume 0.0
3M4 On Other Exchanges
Symbol
Exchange
Berlin
As of 2:09 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

masimo corp (3M4) Snapshot

Open
€23.11
Previous Close
€23.67
Day High
€23.11
Day Low
€23.11
52 Week High
01/27/15 - €23.75
52 Week Low
05/9/14 - €15.83
Market Cap
1.2B
Average Volume 10 Days
18.0
EPS TTM
--
Shares Outstanding
52.4M
EX-Date
11/23/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MASIMO CORP (3M4)

masimo corp (3M4) Related Businessweek News

No Related Businessweek News Found

masimo corp (3M4) Details

Masimo Corporation, a medical technology company, develops, manufactures, and markets various noninvasive patient monitoring products worldwide. The company offers Masimo Signal Extraction Technology (SET), which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry; and Masimo rainbow SET products that monitor multiple blood measurements, including oxygen content, carboxyhemoglobin, methemoglobin, hemoglobin, pleth variability index, respiration rate, Halo Index, and In Vivo Adjustment. It develops, manufactures, and markets a family of patient monitoring solutions comprising monitors, circuit boards, sensors, and cables; Root, a patient monitoring and connectivity platform; Masimo Patient SafetyNet, a remote monitoring and clinician notification solution; and various software products. The company also provides line filters, cannulas, and mainstream adapters; and wafer epitaxy, foundry, and device fabrication services to biomedical, telecommunications, consumer products, and other markets, as well as develops and manufactures ultra-compact mainstream and sidestream capnography, and gas monitoring technologies. Masimo Corporation sells its products to hospitals, emergency medical response organizations, physician offices, veterinarians, long term care facilities, consumers, and alternate care market through its direct sales force and distributors, as well as to original equipment manufacturer partners. The company was founded in 1989 and is headquartered in Irvine, California.

3,139 Employees
Last Reported Date: 02/14/14
Founded in 1989

masimo corp (3M4) Top Compensated Officers

Founder, Chairman and Chief Executive Officer
Total Annual Compensation: $712.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $334.4K
President of Worldwide Oem Business & Corpora...
Total Annual Compensation: $335.7K
President of Worldwide Sales & Marketing and ...
Total Annual Compensation: $332.4K
Chief Information Officer
Total Annual Compensation: $329.2K
Compensation as of Fiscal Year 2013.

masimo corp (3M4) Key Developments

Masimo Corporation Unveils New Fingertip Pulse Oximeter

Masimo Corporation has unveiled the MightySat fingertip pulse oximeter for personal use. MightySat provides accurate oxygen saturation and pulse rate measurements when other pulse oximeters can fail and is ideal for those who want reliable measurements even under extreme conditions. MightySat is available in three versions, each of which provides oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI) measurements in a compact, battery-powered design with a large color screen that can be rotated for real-time display of the pleth waveform as well as measurements. Optional Bluetooth wireless functionality enables measurement display via a free, downloadable app on iOS and Android mobile devices as well as the ability to trend and communicate measurements. And for those who want to use their pulse oximeter to evaluate another physiologic dimension, MightySat is the only fingertip pulse oximeter available with the optional Pleth Variability Index (PVI), a measure of the dynamic changes in the PI that occur during one or more complete respiratory cycles. Other standard features include: signal I.Q. to assess measurement confidence; rugged, lightweight design for operation in challenging environments; long battery life-up to 15 hours with two standard AAA alkaline batteries; and two-year limited warranty.

Masimo Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 04:30 PM

Masimo Corporation Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 04:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Joe E. Kiani, Founder, Chairman and Chief Executive Officer.

Masimo Announces Global Launch of Multigas Monitoring for the Root Patient Monitoring and Connectivity Platform

Masimo announced FDA 510(k) clearance and CE Mark of ISA OR+ multigas monitoring, a Masimo Open Connect (MOC-9) Module for the Root patient monitoring and connectivity platform. During general anesthesia, the ISA OR+ monitors the inhaled and exhaled concentration of five anesthetic gas agents (Sevoflurane, Isoflurane, Halothane, Desflurane, Enflurane), carbon dioxide (CO2), nitrous oxide (N2O), and oxygen (O2), in addition to respiration rate. When technology modules are connected with Root, multiple additional parameters are available including Masimo SET® pulse oximetry, noninvasive and continuous hemoglobin (SpHb), PVI, SedLine brain function monitoring, and O3 Regional Oximetry. Key features and benefits of ISA OR+ include: Requires only 50 ml sampling flow to support monitoring - Time-saving in critical situations with virtually no warm-up time and full accuracy performance in less than 20 seconds - Automatic anesthetic agent identification - Supports monitoring patients with high respiration rates, up to 150 bpm - Low-power consumption and automatic temperature and pressure compensation - Provides minimal alveolar concentration (MAC), which is calculated from the measured anesthetic agents and N2O - Appropriate for monitoring adult, pediatric, or infant patients in a range of clinical environments including the operating room and intensive care unit - Compatible with Masimo's Nomoline Adapter and the Nomoline Airway Adapter Set to interface with endotracheal tubing. O3 Regional Oximetry is FDA 510(k) pending and is not available for sale in the United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3M4:GR €23.11 EUR -0.56

3M4 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CAS Medical Systems Inc $1.55 USD -0.07
Chemed Corp $103.88 USD -1.05
Hutchinson Technology Inc $3.28 USD -0.15
Integra LifeSciences Holdings Corp $56.62 USD -0.67
LiDCO Group PLC 7.63 GBp 0.00
View Industry Companies
 

Industry Analysis

3M4

Industry Average

Valuation 3M4 Industry Range
Price/Earnings 25.2x
Price/Sales 2.6x
Price/Book 5.0x
Price/Cash Flow 23.3x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MASIMO CORP, please visit www.masimo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.